Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Parra, Gabriel I ^a   Azure, JoLynn ^a   Fischer, Renate ^b   Bok, Karin ^a   Sandoval Jaime, Carlos ^a   Sosnovtsev, Stanislav V ^a   Sander, Peter ^b   Green, Kim Y ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b R Biopharm AG Rhome Ltd Scotland   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; PROTEIN VP1; RECOMBINANT PROTEIN; VIRAL PROTEIN; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; CONSERVATION BIOLOGY; CONTROLLED STUDY; CROSS REACTION; GENOTYPE; MOUSE; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PROTEIN DENATURATION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS CHARACTERIZATION; VIRUS LIKE AGENT; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; CHLOROCEBUS AETHIOPS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MUTAGENESIS; SEQUENCE ALIGNMENT; VERO CELL LINE;

GREAT ISLAND VIRUS; MIRIDAE; NOROVIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENOTYPE; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MUTAGENESIS; NOROVIRUS; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; VERO CELLS; VIRAL PROTEINS;

EID: 84879274790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067592     Document Type: Article

References (43)

1. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, et al. (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14: 1224-1231.
2. Green KY (2007) Caliciviridae: The Noroviruses. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia, Pa:Lippincott, Williams & Wilkins. pp. 949-979.
3. Bertolotti-Ciarlet A, Crawford SE, Hutson AM, Estes MK, (2003) The 3′ end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol 77: 11603-11615.
4. Jiang X, Wang M, Graham DY, Estes MK, (1992) Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66: 6527-6532.
5. Green KY, Lew JF, Jiang X, Kapikian AZ, Estes MK, (1993) Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 31: 2185-2191.
6. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, et al. (2011) Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 365: 2178-2187.
7. Herbst-Kralovetz M, Mason HS, Chen Q, (2010) Norwalk virus-like particles as vaccines. Expert Rev Vaccines 9: 299-307.
8. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Estes MK, (2003) Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 108: 241-247.
9. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, et al. (1999) X-ray crystallographic structure of the Norwalk virus capsid. Science 286: 287-290.
10. Debbink K, Donaldson EF, Lindesmith LC, Baric RS, (2012) Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol 86: 1214-1226.
11. Lindesmith LC, Debbink K, Swanstrom J, Vinje J, Costantini V, et al. (2012) Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002. J Virol 86: 873-883.
12. Tan M, Fang P, Chachiyo T, Xia M, Huang P, et al. (2008) Noroviral P particle: structure, function and applications in virus-host interaction. Virology 382: 115-123.
13. Lochridge VP, Jutila KL, Graff JW, Hardy ME, (2005) Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J Gen Virol 86: 2799-2806.
14. Parra GI, Abente EJ, Sandoval-Jaime C, Sosnovtsev SV, Bok K, et al. (2012) Multiple Antigenic Sites are Involved in Blocking the Interaction of GII.4 Norovirus Capsid with ABH Histo-Blood Group Antigens. J Virol 86: 7414-7426.
15. Mesquita JR, Barclay L, Nascimento MS, Vinje J, (2010) Novel norovirus in dogs with diarrhea. Emerg Infect Dis 16: 980-982.
16. Duffy S, Shackelton LA, Holmes EC, (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9: 267-276.
17. Parker TD, Kitamoto N, Tanaka T, Hutson AM, Estes MK, (2005) Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol 79: 7402-7409.
18. Batten CA, Clarke IN, Kempster SL, Oliver SL, Bridger JC, et al. (2006) Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins. Virology 356: 179-187.
19. Oliver SL, Batten CA, Deng Y, Elschner M, Otto P, et al. (2006) Genotype 1 and genotype 2 bovine noroviruses are antigenically distinct but share a cross-reactive epitope with human noroviruses. J Clin Microbiol 44: 992-998.
20. Shiota T, Okame M, Takanashi S, Khamrin P, Takagi M, et al. (2007) Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J Virol 81: 12298-12306.
21. Li X, Zhou R, Tian X, Li H, Zhou Z, (2010) Characterization of a cross-reactive monoclonal antibody against Norovirus genogroups I, II, III and V. Virus Res. 151: 142-147.
22. Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, et al. (2012) Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 30: 3580-3586.
23. Geginat G, Kaiser D, Schrempf S, (2011) Evaluation of third-generation ELISA and a rapid immunochromatographic assay for the detection of norovirus infection in fecal samples from inpatients of a German tertiary care hospital. Eur J Clin Microbiol Infect Dis 31: 733-737.
24. Kirby A, Gurgel RQ, Dove W, Vieira SC, Cunliffe NA, et al. (2010) An evaluation of the RIDASCREEN and IDEIA enzyme immunoassays and the RIDAQUICK immunochromatographic test for the detection of norovirus in faecal specimens. J Clin Virol 49: 254-257.
25. de Bruin E, Duizer E, Vennema H, Koopmans MP, (2006) Diagnosis of Norovirus outbreaks by commercial ELISA or RT-PCR. J Virol Methods 137: 259-264.
26. Bok K, Parra GI, Mitra T, Abente E, Shaver CK, et al. (2011) Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A 108: 325-330.
27. Lew JF, Kapikian AZ, Jiang X, Estes MK, Green KY, (1994) Molecular characterization and expression of the capsid protein of a Norwalk-like virus recovered from a Desert Shield troop with gastroenteritis. Virology 200: 319-325.
28. Leite JP, Ando T, Noel JS, Jiang B, Humphrey CD, et al. (1996) Characterization of Toronto virus capsid protein expressed in baculovirus. Arch Virol 141: 865-875.
29. Holzinger A, Phillips KS, Weaver TE (1996) Single-step purification/solubilization of recombinant proteins: application to surfactant protein B. Biotechniques 20: 804-806, 808.
30. Kohler G, Milstein C, (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
31. Wyatt LS, Moss B, Rozenblatt S, (1995) Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210: 202-205.
32. LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, et al. (2006) Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24: 5220-5234.
33. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS, (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76: 12335-12343.
34. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
35. Tan M, Jiang, (2010) Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog 6: e1000983.
36. Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, et al. (2010) Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 202: 1212-1218.
37. Kwong PD, Wilson IA, (2009) HIV-1 and influenza antibodies: seeing antigens in new ways. Nat Immunol 10: 573-578.
38. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS, (2010) Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol 8: 231-241.
39. Balazs AB, Chen J, Hong CM, Rao DS, Yang L, et al. (2011) Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481: 81-84.
40. Yoda T, Terano Y, Suzuki Y, Yamazaki K, Oishi I, et al. (2000) Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli. Microbiol Immunol 44: 905-914.
41. Li X, Zhou R, Wang Y, Sheng H, Tian X, et al. (2009) Identification and characterization of a native epitope common to norovirus strains GII/4, GII/7 and GII/8. Virus Res 140: 188-193.
42. Almanza H, Cubillos C, Angulo I, Mateos F, Caston JR, et al. (2008) Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II. J Clin Microbiol 46: 3971-3979.
43. Atmar RL, Estes MK (2006) The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am 35::275-290, viii.